Hypersensitivity Reactions Gell and Coombs classification: Type I - - PowerPoint PPT Presentation

hypersensitivity reactions
SMART_READER_LITE
LIVE PREVIEW

Hypersensitivity Reactions Gell and Coombs classification: Type I - - PowerPoint PPT Presentation

Hypersensitivity Reactions Gell and Coombs classification: Type I IgE mediated (allergy) Type II Antibody-mediated cytotoxic Type III Immune Complex mediated Type IV Delayed-Type Hypersensitivity (DTH)


slide-1
SLIDE 1

Hypersensitivity Reactions

  • Gell and Coombs classification:

– Type I – IgE mediated (allergy) – Type II – Antibody-mediated cytotoxic – Type III – Immune Complex mediated – Type IV – Delayed-Type Hypersensitivity (DTH)

  • Types I, II and III are “immediate”
  • Type IV is delayed
slide-2
SLIDE 2

Type I Hypersensitivity

  • Antigens are called “allergens”
  • Unknown why people get allergies, but there is a

strong genetic predisposition (called atopy)

  • Hallmark is inappropriate production of IgE

against allergens that cause mast cell degranulation (see fig 15-2)

  • Normally IgE/mast cell activity should be

directed against parasitic infections

slide-3
SLIDE 3

Type I Hypersensitivity

  • Mediators of Type I hypersensitivites

– Mast cell granule contents (early effects)

  • Histamine and Heparin - ↑ vascular permeability, smooth

muscle contraction (intestines, bronchi), mucus secretion

  • Chemotactic factors – attract eosinophils and neutrophils
  • Proteases – mucus secretion, complement activation,

degradation of blood vessel basement membrane

– Later Effects

  • Leukotrienes and prostaglandins – secreted after tissue

disruption caused by mast cell degranulation, effects are similar to histamine

  • Arrival of proinflammatory eosinophils and neutrophils
slide-4
SLIDE 4
slide-5
SLIDE 5

Clinical Manifestations of Type I

  • Systemic anaphylaxis

– Allergen gets into the blood stream – Dyspnea, ↓BP, bronchole constriction, GI and bladder smooth muscle contration, shock, death within minutes if untreated – Treatment - epinephrine

  • Allergic rhinitis (hay fever)

– Inhaled allergen triggers reaction in nasal mucosa – Watery exudate from nose, eyes, upper respiratory tract, sneeezing and coughing

slide-6
SLIDE 6

Clinical Manifestations of Type I

  • Asthma

– Allergic asthma – due to inhaled airborne allergens (pollens, dust, fumes, etc) – Intrinsic asthma – triggered by cold, exercise – Reaction develops in lower respiratory tract – Bronchoconstriction, airway edema, mucus secretion, inflammation

  • Food allergies

– Ingestion of allergen – Vomiting and diarrhea – If allergens are absorbed into bloodstream, reactions can occur where allergen deposits

  • asthma-like symptoms
  • Urticaria (hives, wheal & flare response)
slide-7
SLIDE 7

Clinical Manifestations of Type I

  • Atopic Dermatitis (allergic eczema)

– Often occurs in young children – Red skin rash – Strong hereditary predisposition

slide-8
SLIDE 8

Type I Hypersensitivity

  • Skin testing

– Potential allergens are injected or scratched into the skin – If the patient is allergic a wheal & flare response

  • ccurs
  • RIST –

radioimmunosorbent test – similar to RIA, non- invasive way to identify allergies

slide-9
SLIDE 9

Type I Hypersensitivity

  • Treatment

– Avoid allergen if possible – Antihistamines, or anti-prostaglandins – Hyposensitization – injections of low doses of allergen may cause a shift from IgE to IgG as the dominant antibody formed.

slide-10
SLIDE 10

Type II Hypersensitivity

  • Antibody-mediated Cytotoxic HS

– Antibodies (IgM or IgG) bind to cell surface

  • antigens. Antigen/antibody complex may lead

to:

  • Complement activation  lysis
  • ADCC
  • Opsonization  phagocytosis

– These are normal reactions, but when they cause unwarranted tissue damage, they are considered a hypersensitivity.

slide-11
SLIDE 11

Type II Hypersensitivity

  • Examples of Type II HS:

– Transfusion reactions

  • To ABO blood groups
  • To other RBC blood groups

– Hemolytic disease of the newborn (erythroblastosis fetalis) – Drug-induced hemolytic anemia (penicillin)

slide-12
SLIDE 12

Type III Hypersensitivity

  • Immune Complex Disease

– Antibody (IgG) / attaching to soluble antigen leads to complex formation – Immune complexes may deposit in:

  • Blood vessel walls (vasculitis)
  • Synovial joints (arthritis)
  • Glomerular basement membrane

(glomerulonephritis)

  • Choroid plexus
slide-13
SLIDE 13

Type III Hypersensitivity

  • Damage occurs due to:

– Anaphylatoxin release due to complement activation (C3a, C5a) which then attracts neutrophils, and causes mast cell degranulation – Neutrophils have trouble phagocytosing “stuck” immune complexes so they release their granule contents leading to more inflammation – Platelet aggregation also results from complement activation

  • These effects are also known as the Arthus

reaction

slide-14
SLIDE 14

Type III Hypersensitivity

  • Localized reactions

– edema and redness (erythema) and tissue necrosis of the affected tissue – Can occur in the skin following insect bites – Can occur in the lungs

  • E.g. “farmer’s lung” from inhaling particles from

moldy hay

slide-15
SLIDE 15

Type III Hypersenstivity

  • Generalized reactions:

– Serum sickness (following treatment with antiserum to a toxin) – Autoimmune diseases

  • SLE
  • Rheumatoid arthritis

– Drug reactions (penicillin) – Infectious diseases

  • Meningitis, hepatitis, malaria, mono etc.
slide-16
SLIDE 16

Type IV Hypersensitivity

  • Delayed type hypersensitivity (DTH)

– TH cells that have been “sensitized” by an antigen develop a TH1 and (sometimes a TC response) leading to macrophage recruitment and activation. – First noticed with reaction to tuberculosis bacteria (tuberculin reaction) – Hallmarks of type IV is the large number of macrophages at the reaction site, and that it takes an average of 24 hrs to manifest after repeat exposure.

slide-17
SLIDE 17